“Achieving Depth of Response in Skin Clearance and Itch Relief With Lebrikizumab is Associated With Minimal Impact of Atopic Dermatitis on Quality of Life”, J of Skin, vol. 9, no. 1, p. s516, Jan. 2025, doi: 10.25251/skin.9.supp.516.